Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health.

Participants needed: 112
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: International AIDS Vaccine InitiativeUpdated: Sep 21, 2026Locations: 3
Eligibility criteria

Adults in good general health [+8]

Any clinically significant acute or chronic medical condition that is considered... [+15]

Status: Recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

A Phase 1 Randomized, Observer Blind, Placebo-controlled, Dose-escalation and dose expansion Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

Participants needed: 112
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: International AIDS Vaccine InitiativeUpdated: Sep 23, 2026Locations: 2
Eligibility criteria

Adults in good general health [+7]

Any clinically significant acute or chronic medical condition that is considered... [+15]

Status: Recruiting

A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.

A Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine (GRAdHIVNE1 Vaccine), Administered to Healthy Adults Living without HIV and Living with HIV, in Southern Africa

Participants needed: 120
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: International AIDS Vaccine InitiativeUpdated: Feb 13, 2026Locations: 3
Eligibility criteria

At least 18 years of age on the day of screening and has not reached his or her... [+12]

Any clinically significant acute or chronic medical condition, other than HIV in... [+3]

Status: Recruiting

A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults and Children Residing in West Africa

Participants needed: 612
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: International AIDS Vaccine InitiativeUpdated: May 11, 2025Locations: 3
Eligibility criteria

Adults, adolescents, and children in good general health as assessed by medical... [+21]

Confirmed HIV-1 or HIV-2 infection (except as outlined for Group 2) [+40]